Full text is available at the source.
Abstract
This cohort study investigates biliary outcomes in youths aged 12 to 21 years using glucagon-like peptide-1 receptor agonists.
- The study focuses on individuals diagnosed with overweight or obesity.
- Biliary outcomes, which relate to the liver and bile production, are examined.
- Findings may provide insights into the effects of glucagon-like peptide-1 receptor agonists on younger populations.
Simplified